1. At a Glance
Axel Polymers makes plastic blends with sci-fi names like Dplon and Dpnor—but delivers profits more fragile than your cousin’s startup idea. With Q1 PAT at just ₹4.39 lakh, the company just approved a ₹12.73 Cr preferential issue to keep things rolling. It’s a micro-cap soap opera… and the latest episode has a rights issue, a GST penalty, and a curious EPS jump.
2. Introduction with Hook
Imagine selling high-tech polymers but barely scraping enough profit to fill a petrol tank. Then imagine raising 12.7 Cr by issuing equity at ₹45/share when your last year’s EPS was ₹0.20. Axel’s story is like watching an F1 race where the car’s made of plastic and still trying to overtake Ferrari.
Throw in a GST penalty, a 66% sales drop TTM, and a preferential allotment to unknown investors—chef’s kiss.
3. Business Model (WTF Do They Even Do?)
Axel Polymers makes polymer compounds with brand names that sound like Marvel villains:
- Dplon = Polycarbonate Compounds
- Dpnor = mPPE Compounds
- Dpnyl = Nylon Compounds
- Dplen, Dprex, Dpron = Other fancy names for plastics
Their clients? Industrial manufacturers looking for engineered plastics. Their margins? Best viewed through a magnifying glass.
“Basically, they mix plastic, brand it like shampoo, and hope the engineering crowd bites.”
4. Financials Overview
Q1
